CELLULAR BIOMEDICINE GROUP, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
CELLULAR BIOMEDICINE GROUP, INC. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $17.75 million as of 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2017-03-13
- 2016-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $17.75M.
- 2015-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $17.75M.
- 2014-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $17.75M.
- 2014-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $17.75M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2016-12-31 | $17.75M 10-K · filed 2017-03-13 |
| 2015-12-31 | $17.75M 10-K · filed 2016-03-14 |
| 2014-12-31 | $17.75M 10-K · filed 2015-04-13 |
| 2014-09-30 | $17.75M 10-Q · filed 2014-11-19 |
| 2014-03-31 | $9.78M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $9.78M 10-K · filed 2014-04-15 |
| 2013-09-30 | $9.78M 10-Q · filed 2013-12-26 |
| 2013-06-30 | $9.78M 10-Q/A · filed 2013-12-06 |